July 19 (Reuters) - Abattis Bioceuticals Corp ATT.CD :
* ABATTIS ENTERS INTO DEFINITIVE AGREEMENT TO SELL NORTHERN VINE INTEREST
* ABATTIS ENTERS INTO DEFINITIVE AGREEMENT TO SELL NORTHERN VINE INTEREST
* ABATTIS BIOCEUTICALS CORP - AGREEMENT WITH EMERALD HEALTH THERAPEUTICS, TO DISPOSE OF ITS 35% INTEREST IN NORTHERN VINE CANADA INC
* ABATTIS - TO DISPOSE ITS 35% INTEREST IN NORTHERN VINE IN EXCHANGE FOR $2 MILLION IN CASH, $4 MILLION IN FREELY TRADEABLE COMMON SHARES OF EMERALD